Your browser doesn't support javascript.
loading
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases.
Hamidi, Sarah; Mahvash, Armeen; Hu, Mimi I.
Afiliación
  • Hamidi S; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA.
  • Mahvash A; Department of Interventional Radiology, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA.
  • Hu MI; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA.
JCEM Case Rep ; 2(8): luae103, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39076377
ABSTRACT
Medullary thyroid carcinoma (MTC) can often have an indolent course despite distant metastatic disease. Additionally, given that metastatic MTC is incurable and systemic therapies have non-negligeable toxicities, localized treatments are often favored in presence of oligo-progressive disease. Transarterial radioembolization (TARE) with yttrium-90 (Y90) has emerged as a safe and efficacious treatment for nonresectable primary and metastatic liver tumors, yet data supporting its use in metastatic MTC are limited. We present the case of a patient with hereditary MTC and large bilobar liver metastases who demonstrated tumor response and resolution of their paraneoplastic diarrhea following TARE with Y90 microspheres.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JCEM Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JCEM Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos